IGC PHARMA, INC. Public Float
IGC PHARMA, INC. (IGC) had Public Float of $18.46 million as of 2025-06-30, per its 10-KT filed 2026-03-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-18
- 2025-06-30: Entity Public Float $18.46M.
- 2024-09-30: Entity Public Float $29.72M.
- 2023-09-30: Entity Public Float $20.88M.
- 2022-09-30: Entity Public Float $20.81M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $18.46M 10-KT · filed 2026-03-18 |
| 2024-09-30 | $29.72M 10-K · filed 2025-06-27 |
| 2023-09-30 | $20.88M 10-K · filed 2024-06-24 |
| 2022-09-30 | $20.81M 10-K · filed 2023-07-07 |
| 2021-09-30 | $70.38M 10-K · filed 2022-06-23 |
| 2020-09-30 | $38.05M 10-K · filed 2021-06-14 |
| 2019-09-30 | $34.79M 10-K · filed 2020-07-13 |
| 2018-09-28 | $193.00M 10-K · filed 2019-06-14 |
| 2017-09-29 | $8.38M 10-K · filed 2018-06-21 |
| 2016-09-30 | $8.79M 10-K · filed 2017-07-14 |
| 2015-09-30 | $2.42M 10-K · filed 2016-07-14 |
| 2014-09-30 | $6.50M 10-K · filed 2015-07-14 |
| 2013-09-30 | $6.50M 10-K · filed 2014-07-15 |
| 2012-09-30 | $10.30M 10-K · filed 2014-07-15 |
| 2011-09-30 | $3.23M 10-K · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |